AstraZeneca Transfers Valeant's European Rights To Troubled Drug By: Investor's Business Daily July 01, 2016 at 09:58 AM EDT Psoriasis drug brodalumab, which Amgen abandoned after suicide reports, will now be marketed in Europe by LEO Pharma. Read More >>